458 related articles for article (PubMed ID: 28548104)
21. Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma.
Liu Z; Yu S; Ye S; Shen Z; Gao L; Han Z; Zhang P; Luo F; Chen S; Kang M
J Proteomics; 2020 Jan; 211():103557. PubMed ID: 31669361
[TBL] [Abstract][Full Text] [Related]
22. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
23. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
[TBL] [Abstract][Full Text] [Related]
24. Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.
Tian B; Chen X; Zhang H; Li X; Wang J; Han W; Zhang LY; Fu L; Li Y; Nie C; Zhao Y; Tan X; Wang H; Guan XY; Hong A
Oncotarget; 2017 Jun; 8(26):42300-42313. PubMed ID: 28404945
[TBL] [Abstract][Full Text] [Related]
25. Whole genome sequencing analysis identifies recurrent structural alterations in esophageal squamous cell carcinoma.
Dutta M; Nakagawa H; Kato H; Maejima K; Sasagawa S; Nakano K; Sasaki-Oku A; Fujimoto A; Mateos RN; Patil A; Tanaka H; Miyano S; Yasuda T; Nakai K; Fujita M
PeerJ; 2020; 8():e9294. PubMed ID: 32617189
[TBL] [Abstract][Full Text] [Related]
26. Novel functional variants locus in PLCE1 and susceptibility to esophageal squamous cell carcinoma: based on published genome-wide association studies in a central Chinese population.
Duan F; Xie W; Cui L; Wang P; Song C; Qu H; Wang K; Zhang J; Dai L
Cancer Epidemiol; 2013 Oct; 37(5):647-52. PubMed ID: 23688607
[TBL] [Abstract][Full Text] [Related]
27. HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamous-cell carcinoma carcinogenesis.
Radojicic J; Zaravinos A; Spandidos DA
Int J Biol Markers; 2012; 27(1):1-12. PubMed ID: 22020370
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.
Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL
Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873
[TBL] [Abstract][Full Text] [Related]
30. RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway.
Zhao H; Yang J; Fan T; Li S; Ren X
Tumour Biol; 2012 Oct; 33(5):1363-74. PubMed ID: 22477709
[TBL] [Abstract][Full Text] [Related]
31. A genetic polymorphism at miR-526b binding-site in the lincRNA-NR_024015 exon confers risk of esophageal squamous cell carcinoma in a population of North China.
Han L; Liu S; Liang J; Guo Y; Shen S; Guo X; Dong Z; Guo W
Mol Carcinog; 2017 Mar; 56(3):960-971. PubMed ID: 27583835
[TBL] [Abstract][Full Text] [Related]
32. Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma.
Takemoto A; Tanimoto K; Mori S; Inoue J; Fujiwara N; Noda T; Inazawa J
Cancer Sci; 2021 Oct; 112(10):4377-4392. PubMed ID: 34263978
[TBL] [Abstract][Full Text] [Related]
33. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
Gen Y; Yasui K; Nishikawa T; Yoshikawa T
Cancer Sci; 2013 Jul; 104(7):810-6. PubMed ID: 23510069
[TBL] [Abstract][Full Text] [Related]
34. Genomic and molecular characterization of esophageal squamous cell carcinoma.
Lin DC; Hao JJ; Nagata Y; Xu L; Shang L; Meng X; Sato Y; Okuno Y; Varela AM; Ding LW; Garg M; Liu LZ; Yang H; Yin D; Shi ZZ; Jiang YY; Gu WY; Gong T; Zhang Y; Xu X; Kalid O; Shacham S; Ogawa S; Wang MR; Koeffler HP
Nat Genet; 2014 May; 46(5):467-73. PubMed ID: 24686850
[TBL] [Abstract][Full Text] [Related]
35. PIK3CA gene mutations and overexpression: implications for prognostic biomarker and therapeutic target in Chinese esophageal squamous cell carcinoma.
Wang L; Shan L; Zhang S; Ying J; Xue L; Yuan Y; Xie Y; Lu N
PLoS One; 2014; 9(7):e103021. PubMed ID: 25054828
[TBL] [Abstract][Full Text] [Related]
36. Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations.
Zhang J; Huang X; Xiao J; Yang Y; Zhou Y; Wang X; Liu Q; Yang J; Wang M; Qiu L; Zheng Y; Zhang P; Li J; Wang Y; Wei Q; Jin L; Wang J; Wang M
PLoS One; 2014; 9(6):e100055. PubMed ID: 24945256
[TBL] [Abstract][Full Text] [Related]
37. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
[TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma.
Kishino T; Niwa T; Yamashita S; Takahashi T; Nakazato H; Nakajima T; Igaki H; Tachimori Y; Suzuki Y; Ushijima T
Mol Carcinog; 2016 Dec; 55(12):2077-2088. PubMed ID: 26756304
[TBL] [Abstract][Full Text] [Related]
39. Genetic variants affecting telomere length are associated with the prognosis of esophageal squamous cell carcinoma in a Chinese population.
Lu Y; Yan C; Du J; Ji Y; Gao Y; Zhu X; Yu F; Huang T; Dai J; Ma H; Jiang Y; Chen J; Shen H; Jin G; Yin Y; Hu Z
Mol Carcinog; 2017 Mar; 56(3):1021-1029. PubMed ID: 27597395
[TBL] [Abstract][Full Text] [Related]
40. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
Ishibashi O; Akagi I; Ogawa Y; Inui T
Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
